Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
BMC Cancer|October 12, 2016
SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trialChristoph Rochlitz, Martin Bigler, Roger von Moos, et al.
Clinical and Translational Radiation Oncology|September 3, 2024
Clinical management of oligometastatic cancer: Applying multidisciplinary tumor board recommendations in practiceSebastian M Christ, Minsu Breitenstein, Philip Heesen, et al.
European Urology Oncology|January 11, 2022
A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14Cyrill A Rentsch, George N Thalmann, Ilaria Lucca, et al.
Nature Medicine|January 24, 2025
Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trialChristian Kurzeder, Bich Doan Nguyen-Sträuli, Ilona Krol, et al.
Scientific Reports|March 6, 2023
A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancerChristoph Mamot, Andreas Wicki, Ursula Hasler-Strub, et al.
Oncotarget|October 21, 2017
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibitionGongda Xue, Reto Kohler, Fengyuan Tang, et al.
BMJ Open|March 26, 2025
Precision Oncology Program (POP), an observational study using real-world data and imaging mass cytometry to explore decision support for the Molecular Tumor Board: study protocolLaura Amanda Boos, Christian Doerig, Gabriele Gut, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2017
PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination TherapyChiara Tarantelli, Eugenio Gaudio, Alberto J Arribas, et al.
Nature Communications|October 31, 2024
Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemiaRebekka Wegmann, Ximena Bonilla, Ruben Casanova, et al.
Cancer Cell|January 22, 2021
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision supportAnja Irmisch, Ximena Bonilla, Stéphane Chevrier, et al.
Pageof 9